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ABSTRACT
Escherichia coli phage PRD1 protein P12, involved in
PRD1 DNA replication in vivo, has been highly purified
from E. coil cells harboring a gene XII-containing
plasmid. Protein P12 binds to single-stranded DNA as
shown by gel retardation assays and nuclease
protection experiments. Binding of protein P12 to
single-stranded DNA increases about 14% the contour
length of the DNA as revealed by electron microscopy.
Binding to single-stranded DNA seems to be
cooperative, and it is not sequence specific. Protein
P12 also binds to double-stranded DNA although with
an affinity 10 times lower than to single-stranded DNA.
Using the in vitro phage 429 DNA replication system,
it is shown that protein P12 stimulates the overall 429
DNA replication.
INTRODUCTION
PRD1 is a lipid-containing bacteriophage infecting a variety of
Gram-negative bacteria harboring an appropriate plasmid. Among
the hosts are Escherichia coli and Salmonella typhimurium (for
review see 1). The genome of the phage is a linear 14.9 kb
double-stranded DNA molecule, which has inverted terminal
repeats of 110 bp (2,3), and a terminal protein (protein P8)
covalently linked to the 5'ends (4,5,6,7,8). The genome is
replicated by a protein-primed mechanism (reviewed in 9), in
which the 5' terminal nucleotide (dGMP) is covalently attached
to a tyrosine residue of the terminal protein (5), probably
catalyzed by the viral polymerase (protein P1). Both the DNA
polymerase and the terminal protein together with proteins P12,
P19 and P15 are viral early gene products. Protein P12 has been
shown to be required for PRD1 DNA replication and shut-off
of early protein synthesis (10). Genetic analysis indicated that
P15 is a lytic enzyme (10), while the function of protein P19
is still unknown.
The best understood protein primed replication systems are
those of adenovirus (reviewed in 11) and Bacillus subtilis phage
429 (9). In addition to DNA polymerase and terminal protein
these viruses code for additional factors needed for replication,
including single-stranded DNA (ssDNA) and double-stranded
DNA (dsDNA) binding proteins. Adenoviruses code for a
multifunctional protein, DBP, which is involved in replication,
transcription control, assembly and transformation. It binds to
ssDNA and, with lower efficiency, also to dsDNA (for reviews
see 11,12). In adenovirus replication DBP cooperates with the
DNA polymerase in the displacement of the non-template strand,
and binds to the displaced ssDNA (13,14). DBP also binds to
dsDNA and enhances binding of NFI to the adenovirus DNA
terminal sequences, thereby stimulating the initiation step ofDNA
replication (15,16). Phage )29 codes for a ssDNA binding protein
(SSB), protein p5, that stimulates in vitro 429 DNA replication
(17) mainly by increasing the ability of 029 DNA polymerase
to reinitiate replication, overcoming the inhibition due to the
increasing amount of ssDNA produced in the reaction (18). A
direct effect of p5 on the initiation step of 429 DNA replication
has not been observed (17). Phage 4)29 also codes for a dsDNA
binding protein, protein p6, which specifically binds to the 429
DNA terminal sequences, stimulating the initiation of 429 DNA
replication (19).
In this study we have purified protein P12 of phage PRD1 and
we have shown that it binds to ssDNA and, with lower efficiency,
also to dsDNA. We have also shown that protein P12 stimulates
in vitro 429 DNA replication.
MATERIALS AND METHODS
Bacterial strains, phages and plasmids
Phage PRD1 (20) was grown on S. typhimurium DS88 (21)
harboring the receptor coding plasmid pLM2 (22), concentrated,
and purified as described previously (23). PRD1 nonsense mutant
in gene XII (susl156) was grown on supressor strain
S.typhimurium DB7156 (10). Phage DNA was extracted after
pronase treatment as previously described (24). The standard
DNA manipulations were done according to (25).
Plasmid pTPH37 (26) that contains genes XII and XIX cloned
into vector pPLH101 (27) under the control of lambda PL
promoter, was deleted by exonuclease III treatment (28) to
remove gene XIX. The clones obtained were sequenced using
the Sanger dideoxy method modified for dsDNA (29) and for
T7 DNA polymerase (30). Plasmid pTPH12 containing
nucleotides 228-787 from the right end of the genome (for
nucleotide numbering see 26) was used for expression of gene
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XH. Plasmid pTPH12 was amplified on either E. coli DH5a
harboring the plasmid pcI857 (31) or E. coli PK466 (8).
The terminal 315 bp fragment of the left end of PRD1 genome
was cloned into Hinc2 restriction site of plasmid pUC18 by H.
Savilahti. For the DNA binding and nuclease protection assays
the fragment was isolated using the adjacent restriction sites, Xbal
and PstJ, in the polylinker site.
Complementation test
PRD1 suslS6 production in E. coli PK466 cells harboring either
plasmids pLM2 and pTPH12, or as a control, plasmids pLM2
and pPLH101, was quantitated by a one step growth-like
procedure as follows: Both bacterial strains were heat-induced
(42°C) at a cell density of 5 x 108 cfu/ml for 25 min (see
below), and then infected at a multiplicity of 0.1. After 5 min,
the remaining unadsorbed phages were inactivated by diluting
the infection mixture 1:10 in growth media containing 1% of
anti-PRD1 polyclonal rabbit serum. After a 5 min incubation with
the antibody, the mixture was further diluted 1: 1000 in
prewarmed growth media and the culture was incubated at
42°C with vigorous shaking. Samples were taken every 10 min
and phage titers were determined on the suppressor strain
S. typhimurium DB7156.
Overproduction and purification of protein P12
E. coli DH5ca(pTPH12, pc1857) was grown at 27°C to cell
density of 5 x 108 cfu/ml, then the temperature was raised to
42°C to induce the lambda PL promoter and after 3 h at 42°C
cells were harvested. Cellular proteins were analyzed before and
after induction by SDS-PAGE (as described in 32). Control cells
harboring the plasmid vector without phage DNA insert were
grown and analyzed in the same way. For protein purification,
cells from a 2 liter culture were harvested, resuspended into 15ml
of 50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM MgCl2 and
5% glycerol, and disrupted in French press. The cell debris was
removed by centrifugation (15 min, 20 000 g) and then the
supernatant was further centrifuged (4 h, 120 000 g). The soluble
fraction was applied to a 6 ml heparin-agarose column. After
washing the column with the same buffer, adsorbed proteins were
eluted by a linear NaCl gradient from 50 mM upto 1 M. Samples
containing P12 were pooled and dialyzed overnight against
50 mM Tris-HCl, pH 7.5 and 50 mM NaCl. The P12 preparation
was then passed through a 5 ml DEAE-agarose column. The
flow-through containing P12 was applied to a 2 ml hydroxyapatite
column equilibrated with the same buffer. Protein P12 was eluted
with 100 mM K-phosphate buffer, pH 7.5 and concentrated to
about S mg/ml by dialysis against solid PEG 20 000. Glycerol
was added up to 30% and samples were stored in aliquots at
-70°C. Approximately 10-12 mg of protein could be obtained
from a 2 liter culture. The molecular weight of the native protein
P12 was determined by centrifugation of purified protein P12
(rotor SW41, 35 000 rpm, 6°C, 48 h) in a 5%-20% sucrose
gradient in 50 mM Tris-HCl, pH 7.5 and 50 mM NaCl. Rabbit
muscle aldolase (158 kDa), bovine serum albumin (67 kDa) and
horse heart cytochrome c (12 kDa) were used as molecular weight
markers.
Gel retardation assays
Gel retardation assays were carried out essentially as previously
described (33). Protein P12, at the indicated amounts, was
incubated 30 min on ice with end labelled 315 bp DNA fragment
(-5 ng, -S00cpm) in 20 yl of 50 mM Tris-HCI pH 7.5,
50 mM NaCl, 20 mM (NH4)2SO4, 10 mM MgCl2, 1 mM DTT
and 2,ug BSA. When binding to ssDNA was assayed, the dsDNA
fragment was denatured by heating for 3 min at 95°C before
incubation with the protein. The protein-DNA complexes were
resolved in 4% polyacrylamide gels (acrylamide: bis-acrylamide
80:1). After electrophoresis in TBE buffer (25) the gels were
dried and autoradiographed.
Protection of ssDNA against nuclease P1
Heat-denatured nick-translated DNA fragment (- 10 ng) from
the left terminus of PRD1 genome was incubated with the
indicated amounts of protein P12 in 30 mM Tris-acetate, pH 7.5,
10 mM MgCl2, and 0.1 mM ZnCl2 as described in (17).
Protein-DNA mixture (total volume 25AI) was incubated 30 min
on ice before treatment with nuclease P1 (41tg) for 5 min at 30°C.
The reaction was stopped by adding 25,ul of tRNA (0.4 mg/ml)
and 50,u of 14% ice cold TCA. Samples were kept on ice for
45 min and centrifuged 15 min in an Eppendorf centrifuge. Pellets
were washed once and the radioactivity in supernatants and pellets
was determined.
Electron microscopy
Protein P12 (6/g) was incubated with M13mp8 ssDNA (mass
ratio 40: 1) in the buffer used for in vitro 4t29 p3-DNA replication
(described below). After 20 min at 30°C, free protein was
removed by gel filtration through a Sepharose CL 4B column
equilibrated with 7 mM magnesium acetate. Fractions were
collected in tubes containing glutaraldehyde to give a final
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Figure 1. Purification of protein P12. Samples at different purification steps
analyzed by SDS-PAGE: lane a) proteins of phage 06 used as molecular weight
markers (1), b) disrupted cells after centrifugations, c) P12-containing fractions
from the heparin-agarose column, d) flow-through from the DEAE-agarose
column, e) P12 eluted from the hydroxyapatite column. The position of P12 is
indicated on the right.
Nucleic Acids Research, Vol. 18, No. 22 6555
concentration of 0.1 %. After 1 hour at room temperature,
samples were prepared for electron microscopy according to the
BAC spreading technique (34). Single stranded M13 DNA was
added just before spreading and was used as an internal control
for contour length measurements. Samples were picked up with
standard carbon coated grids pretreated with uranyl acetate and
rotary shadowed with platinum. Micrographs were taken in a
Philips 420 electron microscope at 100 kV and at a magnification
of 18500 x. Contour length was determined in a HP Digitizer.
Replication assay using q529 DNA
Replication assays with c29 DNA-terminal protein as template
using purified 029' DNA polymerase (p2) and 029 terminal
protein (p3) were carried out as described in (17). The incubation
mixture (total volume 201l) contained 50 mM Tris-acetate,
pH 7.5, 10 mM Mg-acetate, 1 mM dithiothreitol, 10 mM
(NH4)2SO4, 20 mM NaCl, 25,ug bovine serum albumin, 029
DNA-terminal protein (220 ng), 40/tM each dCTP, dGTP, dTTP
and [a-32P]dATP (2u Ci) and purified proteins p2 (24 ng) and
p3 (15 ng). Incubation was carried out at 30°C for the indicated
times in the absence or presence of the indicated amounts of
PRD1 protein P12. Reactions were stopped with 10 mM EDTA
and 0.1 % SDS, filtered through Sephadex G-50 spun columns
in the presence of 0.1% SDS, and the Cerenkov radiation of the
excluded volume was measured. When the rate of elongation was
to be determined, the labelled DNA from the excluded volume
was subjected to gel electrophoresis in 0.7% alkaline agarose gels.
Initiation of the replication was assayed essentially as described
above except that [a-32P]dATP (2/A Ci) was the only dNTP
present. After 10 min at 30°C the reaction was stopped, and
samples were treated with micrococcal nuclease and subjected
to SDS-polyacrylamide gel electrophoresis.
RESULTS AND DISCUSSION
Expression and purification of protein P12
The ability of plasmid pTPH12, containing gene XII under the
control of lambda PL promoter, to produce biologically active
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protein P12 was analyzed by complementation of a nonsense
mutation in gene XII. Due to the leakiness of the suslS6 mutant,
standard complementation could not be carried out, but instead
an one step growth-like experiment was done. E. coli PK466
non-suppressor cells harboring plasmids pLM2 and pTPH12, or
control cells harboring plasmids pLM2 and pPLH101, were
infected with phage PRD1 suslS6, and phage titers of the infected
cultures were determined on a suppressor host at different times
after infection. At 90 min post-infection, the phage production
was 7-10 times higher in cells harboring pTPH12 than in control
cells. Therefore, protein P12 produced from the plasmid during
the heat induction is able to complement the suslS6 PRD1
mutation.
Purification of protein P12 was carried out as described in
Materials and Methods and is summarised in Fig. 1. Most of
the contaminant proteins are removed during the chromatography
on heparin-agarose. The few contminants still left were removed
by the DEAE-agarose and hydroxyapatite chromatography. The
P12 obtained was at least 95% pure. Degradation of P12 was
observed depending on the particular E. coli strain used for the
expression. E. coli PK466 produced an approximately 13 kDa
fragment in addition to the native protein P12. The degradation
was markedly deminished when E. coli DH5a(pCI857) was used
as a host. The degradation product was identified as a P12
derivative by gel electrophoresis analysis of samples incubated
at room temperature in the absence or presence of the proteinase
inhibitor PMSF. This degradation product can be separated from
P12 during the heparin-agarose step, since it elutes at lower NaCl
concentration than P12.
By sucrose gradient centrifugation, native protein P12 had an
apparent molecular weight about 12 kDa. The molecular weight
determined from the DNA sequence is 16,7 kDa (26). The
sedimentation behaviour of P12 is consistent with monomeric
state.
DNA binding properties of protein P12
To test the ability of P12 to bind to DNA, gel retardation assays
were carried out with different amounts of P12 and either ssDNA
or dsDNA (Fig 2.). Protein P12 formed a well defined complex
with ssDNA that moved at the same position as P12 alone, as
determined by Coomassie-blue staining of the retarding gel. The
minimal amount of protein P12 needed to change the mobility
of the ssDNA fragment was around 150 ng; a relatively small
increase in the amount of the protein was needed to retard all
P12-
Figure 2. Gel retardation assay of the binding of protein P12 to ssDNA and
dsDNA. The DNA fragment used in the assay was the terminal 315 bp fragment
from the left end of the PRD1 genome. Binding to ssDNA is shown in panel
A and binding to dsDNA in panel B. The protein amounts used were 0 ng in
lanes a) and j); 15 ng in b); 30 ng in c); 75 ng in d); 150 ng in e); 300 ng in
f); 750 ng in g); 1.5yg in h); and 2.5lig in i). The position of protein P12 is
indicated on the left.
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Figure 3. Protection of ssDNA by protein P12 against nuclease P1. The DNA
fragment used in the reaction was the heat-denatured 315 bp left terminal fragment
from PRD1. The percent of radioactivity indicates the proportion of trichloroacetic
acid-precipitated material in the sample after nuclease treatment in the presence
of different amounts of P12.
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Figure 4. Complexes of protein P12 with ssM13 DNA. A) Structure of the
complexes. Purified P12 was incubated with M 13 ssDNA. DNA-protein complexes
were purified and visualized under the electron microscope as described in Material
and Methods. M13 ssDNA molecules, used as an internal control, are also shown.
The bar represents 0.5ytm (1215 nt). B) Contour length measurements of protein-
free M13 ssDNA (white histogram) and P12-DNA complexes (shadowed
histogram). Arrows point to the mean values of each size distribution (268.3 and
306.3 units for protein-free DNA and complexes, respectively). A total of 37
molecules were measured in each case (50 units correspond to 1359 nt)
the input ssDNA, suggesting that P12 binds to ssDNA in a
cooperative way. In addition, P12 was able to retard dsDNA at
a minimal protein concentration 10 times greater than that
required for retarding ssDNA. The retarded dsDNA bands were
more diffuse than the retarded ssDNA band, suggesting that
complexes between dsDNA and P12 are not as uniform and/or
stable as those formed with ssDNA. Furthermore, P12 was able
to protect ssDNA against nuclease digestion (Fig. 3). Maximal
protection against nuclease P1 was reached with approximately
the same amount of protein that was needed for P12-ssDNA
complex formation in the gel retardation assay. Binding of P12
to DNA is not sequence specific since it binds to M13 ssDNA
(see below), and it retards dsDNA fragments from plasmid
pUC 18 with the same efficiency as the terminal PRD1 fragment
(results not shown). These DNA binding properties of P12
resemble those of adenovirus DBP that also binds to both ssDNA
and, with lower efficiency, to dsDNA (15,16). On the contrary,
binding of the 029 SSB protein p5 to dsDNA is barely detectable
(17).
Electron microscopy of P12-ssM13 DNA complexes
Since protein P12 binds preferentially to ssDNA it was interesting
to analyze the structure of such DNA-protein complexes by direct
observation under the electron microscope. Under the conditions
used, P12 efficiently associates with M13 ssDNA, covering
completely the DNA molecule (Fig. 4A). DNA-protein
complexes had a smoothly contoured appearance, similar to that
found for complexes formed between M 13 ssDNA and 429 SSB
protein p5 (18) or E. coli SSB at a high SSB to DNA ratio (35).
Interaction of SSB proteins with ssDNA frequently leads to a
change in the contour length of the corresponding protein-free
ssDNA molecule (36). Contour length of both protein-free M 13
ssDNA and P12-M13 ssDNA complexes found in the same grid
was measured. In both cases, the length distributions fitted to
A
Figure 5. The stimulation of 029 DNA replication by P12. A) 29 DNA template was incubated with purified 429 DNA polymerase, 29 terminal protein and 40uM
dNTP, in the absence or presence of P12, and the samples were processed as described in Materials and Methods. The amount of radioactivity incorporated during
the time course of replication is shown in the graph. The amount of P12 used is indicated beside each curve. B) To determine the size of newly synthesized DNA
products, samples from the replication assay shown in panel A were analyzed in alkaline agarose gel electrophoresis. Samples after 5 min, 10 min and 20 min replication
are shown in lanes a) to d), e) to h), and i) to 1), respectively. The amounts of P12 used were 0 ng in lanes a), e) and i); 250 ng in lanes b), f) and j); 500 ng
in lanes c), g) and k); and 114g in lanes d), h) and 1).
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Figure 6. The effect of P12 on the initiation of 429 DNA replication. Initiation
reactions were carried out at different dATP concentrations, in the absence (-)
or presence (+) of 2.51Lg of P12, and the samples were analyzed in SDS-PAGE
after 10 min of reaction.
a Gaussian curve (Fig. 4B). Comparison of the mean values
indicated that interaction between P12 and M13 ssDNA produced
about 14% increase in the DNA length. Although SSB proteins
usually decrease the ssDNA contour length upon interaction, a
40% increase in the length of ssDNA has been also reported after
binding of T4 gp32 to OX 174 ssDNA (37).
Stimulation of 429 DNA replication by protein P12
Phage PRD1 replicates by a protein-priming mechanism similar
to that of phage )29 (for review see 9). Since an in vitro DNA
replication system with purified components for PRD1 is not yet
available, the effect of protein P12 was assayed in the in vitro
429 DNA replication system (38). 429 DNA replication was
measured using 429 terminal protein, 429 DNA polymerase, and
429 DNA-terminal protein complex as template (Fig. 5A). As
previously described for this minimal system, DNA replication
reached a plateau after 10 min (17). In the presence of protein
P12, DNA replication was stimulated in a dose-dependant manner
(Fig. SA). About a 3-fold stimulation was obtained with 2.5t4g
of protein P12 at 40 min, when the plateau was reached (results
not shown). When the DNA replication products were analyzed
by alkaline agarose gel electrophoresis, it could be seen that the
average length of the replication products were roughly the same
both in the absence or presence of protein P12. (Fig. 5B).
Therefore, it seems that protein P12 does not stimulate
significantly the rate of elongation, but rather it increases the
amount of molecules replicated. A similar effect has been shown
for the 429 SSB protein p5 (17). 429 SSB protein p5 stimulates
429 DNA replication mainly by increasing the ability of the DNA
polymerase to reinitiate DNA replication, overcoming the
inhibition due to the ssDNA formed during the reaction (18).
Therefore, it is likely that the same mechanism operates in the
case of P12.
When the effect of protein P12 on the initiation of 429 DNA
replication was studied using dATP as the only dNTP present
in the incubation mixture, no stimulation of the terminal protein-
dAMP initiation complex was observed up to 10tM dATP.
However, about 2-fold stimulation was obtained at higher dATP
concentrations (Fig. 6). Since transition from initiation to the first
elongated products, terminal protein-(dAMP)3, only takes place
at high dATP concentrations (39), P12 likely affects this step
in the initiation reaction. This stimulation could be related to the
ability of P12 to bind dsDNA. The relevance of this stimulation
to the overall DNA replication process remains to be determined.
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